Acutus Medical, Inc. [●] Shares of Common Stock, par value $0.001 per share Underwriting AgreementAcutus Medical, Inc. • July 12th, 2021 • Surgical & medical instruments & apparatus • New York
Acutus Medical, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom Goldman Sachs & Co. LLC (“Goldman Sachs”) is acting as representative (the “Representative”), an aggregate of [●] shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [●] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.” To the extent there are no additional Underwriters listed on Schedule 1 other than you, the term Representatives as used herein shall mean you, as Underwriter, and the terms Representatives and Underwriters shall mean either the singular or p
Feasibility and Development AgreementFeasibility and Development Agreement • July 12th, 2021 • Acutus Medical, Inc. • Surgical & medical instruments & apparatus
